In myeloma, re-expressing wild-type PTEN in PTEN-deficient cells represses proliferation and invasion by downregulating FAK, MMP2 and MMP9 expression and activity [68], indicating that HPSE and PTEN are targeting expression of the same proteins but in opposite ways. This evidence concerns the gene PTEN and plasma cell myeloma.